-
Most doctors get little training in the science of obesity or how to counsel people with the disease. As a result, many patients experience stigma in the exam room.
-
The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.
-
Instead of "watchful waiting," the American Academy of Pediatrics recommends intensive lifestyle and behavior therapy for young kids; and for older children, medication.
-
A new wave of obesity care startups offer access to new weight loss medications. But do they offer good health care?
-
People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.
-
The body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.
-
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person’s stomach, to help people eat less. Results vary widely but are modest on average.
-
The Association of American Medical Colleges plans to roll out new diversity, equity, and inclusion standards aimed at teaching doctors, among other things, how to treat patients who are overweight with respect.
-
New research adds to growing concern over zero-calorie drinks. Consuming artificial sweeteners may confuse our body, leading to increased hunger and weight gain.
-
Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.